Jacques Gonella
Directeur/Membre du Conseil chez APR Applied Pharma Research SA
Profil
Jacques Gonella was the founder of Permatec Holding AG, which was founded in 1997, where he held the title of Chairman.
He was also the founder of SkyePharma AG, which was founded in 1983, where he held the title of President & Chief Executive Officer.
Currently, Dr. Gonella is an Independent Director at APR Applied Pharma Research SA and a Director at Esocap AG.
In the past, he served as an Independent Director at Antares Pharma, Inc. from 2008 to 2019, and as a Non-Executive Director at Protherics Plc in 2007 and 2008.
Dr. Gonella obtained a doctorate degree from École Polytechnique Fédérale de Lausanne.
Postes actifs de Jacques Gonella
| Sociétés | Poste | Début |
|---|---|---|
APR Applied Pharma Research SA
 APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Directeur/Membre du Conseil | - |
Esocap AG
 Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jacques Gonella
| Sociétés | Poste | Fin |
|---|---|---|
| ANTARES PHARMA, INC. | Président | 01/10/2008 |
Protherics Plc
 Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK. | Directeur/Membre du Conseil | 04/12/2008 |
| SkyePharma AG | Directeur Général | 01/05/1996 |
Permatec Holding AG
 Permatec Holding AG Medical SpecialtiesHealth Technology Part of Halozyme Therapeutics, Inc., Permatec Holding AG develops novel transdermal and buccal drug delivery systems. The company is based in Allschwil, Switzerland. The Swiss company was founded by Jacques Gonella. Permatec Holding was acquired by Antares Pharma, Inc., part of Halozyme Therapeutics, Inc. from May 25, 2022 on February 01, 2000. | Fondateur | - |
Formation de Jacques Gonella
| École Polytechnique Fédérale de Lausanne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Protherics Plc
Protherics Plc Pharmaceuticals: MajorHealth Technology Protherics Plc researches, develops, and manufactures biopharmaceutical products. It provides critical care and cancer related products. Its products include CroFab, DigiFab, and ViperaTAb. It has offices in the United Kingdom, the United States, and Australia. The company was founded in 1987 and is headquartered in London, UK. | Health Technology |
Permatec Holding AG
Permatec Holding AG Medical SpecialtiesHealth Technology Part of Halozyme Therapeutics, Inc., Permatec Holding AG develops novel transdermal and buccal drug delivery systems. The company is based in Allschwil, Switzerland. The Swiss company was founded by Jacques Gonella. Permatec Holding was acquired by Antares Pharma, Inc., part of Halozyme Therapeutics, Inc. from May 25, 2022 on February 01, 2000. | Health Technology |
| SkyePharma AG | |
APR Applied Pharma Research SA
APR Applied Pharma Research SA BiotechnologyHealth Technology APR Applied Pharma Research SA develops and licenses healthcare products and technologies. It specializes in the development of oral and topical formulations in various healthcare regulatory areas ranging from Rx and OTC pharmaceuticals, nutraceuticals, dermocosmetics, and medical devices. The company was founded in 1990 and is headquartered in Balerna, Switzerland. | Health Technology |
Esocap AG
Esocap AG Pharmaceuticals: MajorHealth Technology Esocap AG is a privately funded company based in Basel, Switzerland. The Swiss company's vision is to improve the lives of patients with serious diseases of the upper gastrointestinal tract through the development of a unique and innovative topical drug delivery platform. The company is cooperating with key R&D and industrial partners, including the University of Greifswald, where the Esocap technology was invented by Prof. Werner Weitschies and his team. Esocap has filed several worldwide patents for their technology, which includes a capsule holder and production methods. The CEO of the company is Isabelle Racamier. | Health Technology |
